The metabolic syndrome and stroke -: Potential treatment approaches

被引：61
作者：
Arenillas, Juan F.
Moro, Maria A.
Davalos, Antoni
机构：
[1] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Dept Neurosci, Stroke Unit, Badalona 08916, Spain
[2] Univ Complutense, Sch Med, Dept Pharmacol, E-28040 Madrid, Spain
来源：
STROKE | 2007年 / 38卷 / 07期
关键词：
D O I：
10.1161/STROKEAHA.106.480004
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：2196 / 2203
页数：8
相关论文
共 81 条
  • [71] Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study
    Rutter, MK
    Meigs, JB
    Sullivan, LM
    D'Agostino, RB
    Wilson, PW
    [J]. DIABETES, 2005, 54 (11) : 3252 - 3257
  • [72] A peroxisome proliferator-activated receptor-γ agonist reduces infarct size in transient but not in permanent ischemia
    Shimazu, T
    Inoue, I
    Araki, N
    Asano, Y
    Sawada, M
    Furuya, D
    Nagoya, H
    Greenberg, JH
    [J]. STROKE, 2005, 36 (02) : 353 - 359
  • [73] Abdominal obesity and risk of ischemic stroke - The Northern Manhattan Stroke Study
    Suk, SH
    Sacco, RL
    Boden-Albala, B
    Cheun, JF
    Pittman, JG
    Elkind, MS
    Paik, MC
    [J]. STROKE, 2003, 34 (07) : 1586 - 1592
  • [74] Peroxisome proliferator-activated receptor-γ ligands reduce inflammation and infarction size in transient focal ischemia
    Sundararajan, S
    Gamboa, JL
    Victor, NA
    Wanderi, EW
    Lust, WD
    Landreth, GE
    [J]. NEUROSCIENCE, 2005, 130 (03) : 685 - 696
  • [75] Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus
    Wannamethee, SG
    Shaper, AG
    Lennon, L
    Morris, RW
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (22) : 2644 - 2650
  • [76] Peroxisome proliferator-activated receptor γ and metabolic disease
    Willson, TM
    Lambert, MH
    Kliewer, SA
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 : 341 - 367
  • [77] Cardiovascular risk factors emerge after artificial selection for low aerobic capacity
    Wisloff, U
    Najjar, SM
    Ellingsen, O
    Haram, PM
    Swoap, S
    Al-Share, Q
    Fernström, M
    Rezaei, K
    Lee, SJ
    Koch, LG
    Britton, SL
    [J]. SCIENCE, 2005, 307 (5708) : 418 - 420
  • [78] Drug therapy: Thiazolidinediones
    Yki-Jarvinen, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (11) : 1106 - 1118
  • [79] The PROactive study:: some answers, many questions
    Yki-Järvinen, H
    [J]. LANCET, 2005, 366 (9493) : 1241 - 1242
  • [80] Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ
    Yuan, MS
    Konstantopoulos, N
    Lee, JS
    Hansen, L
    Li, ZW
    Karin, M
    Shoelson, SE
    [J]. SCIENCE, 2001, 293 (5535) : 1673 - 1677
123456789